TSCAN THERAPEUTICS, INC. (TCRX) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $11.71M; Long-term Debt, Excluding Current MaturitiesUSD $21.07M; Long-term DebtUSD $32.78M; Long-Term Debt, Maturity, Year OneUSD $16.25M.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $32.65M; Long-term DebtUSD $32.65M; Long-Term Debt, Maturity, Year OneUSD $4.06M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $32.53M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $32.53M; Long-Term Debt, Maturity, Year OneUSD (m).
TSCAN THERAPEUTICS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Debt Instrument, Interest Rate During Period pure | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.71M | $21.07M | $32.78M | $16.25M | $12.19M | (m) | (m) | (m) | $4.06M | $32.50M | (m) | $1.35M |
| 2026-03-31 | (m) | $32.65M | $32.65M | $4.06M | $16.25M | $12.19M | (m) | (m) | (m) | $32.50M | (m) | $1.47M |
| 2025-12-31 | (m) | $32.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $32.53M | (m) | $4.06M | $16.25M | $12.19M | (m) | (m) | $32.50M | (m) | $1.59M |
| 2025-09-30 | (m) | $32.41M | $32.41M | (m) | (m) | $4.06M | $16.25M | $12.19M | (m) | $32.50M | (m) | $1.71M |
| 2025-06-30 | (m) | $32.30M | $32.30M | (m) | (m) | $4.06M | $16.25M | $12.19M | (m) | $32.50M | (m) | $1.83M |
| 2025-03-31 | (m) | $32.18M | $32.18M | (m) | (m) | $4.06M | $16.25M | $12.19M | (m) | $32.50M | (m) | $1.94M |
| 2024-12-31 | (m) | $32.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $32.07M | (m) | (m) | $4.06M | $16.25M | $12.19M | (m) | $32.50M | (m) | $2.05M |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 12.57% | (m) |
| 2024-09-30 | (m) | $30.65M | $30.65M | (m) | (m) | $9.66M | $20.34M | (m) | (m) | $30.00M | (m) | $1.15M |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 12.82% | (m) |
| 2024-06-30 | $10.34M | $20.11M | $30.45M | (m) | $3.43M | $14.59M | $11.98M | (m) | (m) | $30.00M | (m) | $1.35M |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 12.82% | (m) |
| 2024-03-31 | $6.80M | $23.45M | $30.25M | (m) | $3.43M | $14.59M | $11.98M | (m) | (m) | $30.00M | (m) | $1.55M |
| 2023-12-31 | $3.35M | $26.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 12.82% | (m) |
| 2023-12-31 | (m) | (m) | $30.05M | (m) | $3.43M | $14.59M | $11.98M | (m) | (m) | $30.00M | (m) | $1.75M |
| 2023-09-30 | $1.11M | $28.84M | $29.95M | (m) | $3.43M | $14.59M | $11.98M | (m) | (m) | $30.00M | (m) | $1.85M |
| 2023-06-30 | (m) | $29.72M | $29.72M | (m) | $3.43M | $14.59M | $11.98M | (m) | (m) | $30.00M | (m) | $2.08M |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 13.13% | (m) |
| 2023-03-31 | (m) | $29.50M | $29.50M | (m) | $3.43M | $14.59M | $11.98M | (m) | (m) | $30.00M | (m) | $2.30M |
| 2022-12-31 | (m) | $29.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · 13.13% | (m) |
| 2022-12-31 | (m) | (m) | $29.29M | (m) | $3.43M | $14.59M | $11.98M | (m) | (m) | $30.00M | (m) | $2.51M |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 13.13% | (m) |
| 2022-09-30 | (m) | $29.07M | $29.07M | (m) | $3.43M | $14.59M | $11.98M | (m) | (m) | $30.00M | (m) | $2.73M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |